z-logo
open-access-imgOpen Access
The role of trabectedin as second-line treatment of advanced soft tissue sarcoma: update of key efficacy and safety data
Author(s) -
Axel Le Cesne
Publication year - 2022
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2022-0516
Subject(s) - trabectedin , medicine , soft tissue sarcoma , oncology , soft tissue , key (lock) , sarcoma , first line , surgery , pathology , computer science , computer security

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom